Ozempic, containing the active ingredient semaglutide, belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class. It was originally developed for type 2 diabetes management and, in certain cases, medical weight control.
However, Ozempic has recently become widely popular on social media as a “quick fix” for weight loss. While this growing trend may sound appealing, it has raised serious concerns about both physical and psychological health.
Potential Risks of Ozempic
Impact on Eating Disorders
By suppressing appetite and increasing feelings of fullness, Ozempic can lead to harmful effects for people with a history of anorexia nervosa, bulimia, or binge eating disorder. The drug may unintentionally reinforce restrictive behaviours, meal skipping, and obsessive calorie counting.
Rapid weight loss can also harm body image, lower mood, and reduce mental resilience. Additionally, prolonged calorie restriction can contribute to muscle loss and weakened bone health.
Psychological Dependence
Because Ozempic reduces the brain’s “food reward” response, eating may feel less enjoyable. Over time, some individuals may rely on the medication as their only means of appetite control. Once discontinued, the sudden return of hunger may trigger anxiety, fear of weight regain, and even disordered eating patterns.
Physical and Metabolic Side Effects
Common side effects include nausea, vomiting, diarrhoea, and stomach discomfort. If hydration and electrolyte balance are not carefully managed, these symptoms can worsen.
Some patients also experience gastroparesis (slowed stomach emptying), which disrupts digestion and eating patterns. Since the long-term effects of semaglutide are still being researched, potential impacts on bone health, hormonal balance, and mental well-being remain a concern.
Potential Links to Blindness and Liver Damage
Recent medical discussions have pointed to a possible connection between Ozempic and vision problems. Some patients have reported retinopathy or even sudden vision loss. Although research is still ongoing, individuals with diabetes may face a higher risk since they are already vulnerable to eye complications.
There are also concerns about liver health. Some studies suggest that semaglutide can lead to elevated liver enzymes or, in rare cases, liver injury. The risk may be greater for people with pre-existing liver conditions or long-term use of the drug. While the evidence is inconclusive, these reports underline the importance of using Ozempic only under close medical supervision.
In addition, some serious health concerns have been reported in connection with Ozempic use. These include gastroparesis (also known as stomach paralysis or delayed gastric emptying), intestinal obstruction, vision loss, particularly NAION (non-arteritic anterior ischemic optic neuropathy), and gallbladder-related complications. There are also claims that it may have potential effects on other organs such as the kidneys and pancreas. While these findings are not conclusive, it is important for patients to be aware of the possible risks and to consult a healthcare professional if they experience any concerning symptoms.
Who Is at Higher Risk?
- People with a history of eating disorders.
- Underweight individuals or those with low BMI, especially when using high doses.
- Adolescents and young adults, still developing physically and psychologically.
- Individuals with existing psychological vulnerabilities related to self-image.
- Those using Ozempic without professional medical supervision, often influenced by social media trends.
Alternatives to Ozempic at Clinic Center
For patients who are concerned about the risks of Ozempic and other similar medications, Clinic Center offers safe, long-term solutions with surgical and non-surgical bariatric treatments. Each procedure is carried out by experienced surgeons under international healthcare standards, with full aftercare support.
- Gastric Sleeve (Sleeve Gastrectomy) – Removes a large part of the stomach to limit food intake and promote early satiety.
- Gastric Bypass – Both reduces stomach size and changes the digestive pathway to limit calorie absorption.
- Gastric Balloon – A temporary, non-surgical option that lowers stomach capacity.
All treatments are offered as part of comprehensive packages, including accommodation, VIP transfers, and dedicated aftercare services to ensure patient safety and comfort.
Conclusion: Informed Decisions Matter
Ozempic and similar GLP-1 receptor agonists may help some people, particularly those with serious obesity-related health concerns. However:
- They are not universally safe.
- Risks such as eating disorder relapse, psychological strain, and physical side effects must be considered.
- Anyone considering Ozempic should only do so under the supervision of a multidisciplinary team, including an endocrinologist, dietitian, and psychologist.
At Clinic Center, patients seeking sustainable weight-loss solutions can explore safer and more effective alternatives, supported by a trusted British company with more than 10 years of experience in the healthcare sector and surgeons with over 25 years of expertise.
